ASKP1240 in De Novo Kidney Transplant Recipients

被引：0
|
作者：
Harland, R. [1 ]
Klintmalm, G. [2 ]
Yang, H. [3 ]
Jensik, S. [4 ]
Shah, T. [5 ]
West-Thielke, P. [6 ]
Shihab, F. [7 ]
Zhang, W. [8 ]
Santos, V. [8 ]
Tainaka, R. [8 ]
Wang, X. [8 ]
First, R. [8 ]
Holman, J. [8 ]
机构：
[1] E Carolina Univ, Greenville, NC USA
[2] Baylor Univ, Med Ctr, Dallas, TX USA
[3] Pinnacle Hlth Syst, Harrisburg, PA USA
[4] Rush Univ, Chicago, IL 60612 USA
[5] Transplant Res Inst, Los Angeles, CA USA
[6] Univ Illinois, Chicago, IL USA
[7] Univ Utah, Hlth Sci Ctr, Salt Lake City, UT USA
[8] Astellas Pharma Global Dev, Northbrook, IL USA
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2015年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
3012
引用
收藏
页数：1
相关论文
共 50 条
  • [11] De novo renal cell carcinoma of native kidney in renal transplant recipients
    Neuzillet, Y
    Lay, F
    Luccioni, A
    Daniel, L
    Berland, Y
    Coulange, C
    Lechevallier, E
    CANCER, 2005, 103 (02) : 251 - 257
  • [12] Infections in de novo kidney transplant recipients treated with the RANKL inhibitor denosumab
    Bonani, Marco
    Frey, Diana
    De Rougemont, Olivier
    Mueller, Nicolas
    Mueller, Thomas
    Graf, Nicole
    Wuthrich, Rudolf
    SWISS MEDICAL WEEKLY, 2016, 146 : 7S - 7S
  • [13] Does de novo malignancy increase the risk of rejection in kidney transplant recipients?
    Demir, Erol
    Tamer Dincer, Mevlut
    Karaca, Cebrail
    Erel, Cansu
    Karahan, Latif
    Pekmezci, Aslihan
    Trabulus, Sinan
    Seyahi, Nurhan
    Turkmen, Aydin
    TRANSPLANTATION, 2024, 108 (9S)
  • [14] De Novo Anti-HLA Sensitization in Pediatric Kidney Transplant Recipients
    Vila-Santandreu, A.
    Camacho, J.
    Vila-Cots, J.
    Ramos, M.
    Gondra, L.
    Martorell, J.
    TRANSPLANTATION, 2014, 98 : 672 - 672
  • [15] Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in de Novo Pediatric Kidney Transplant Recipients
    Zhao, Wei
    Elie, Valery
    Roussey, Gwenaelle
    Brochard, Karine
    Niaudet, Patrick
    Deschenes, Georges
    Cochat, Pierre
    Cloarec, Sylvie
    Andre, Jean Luc
    Tsimaratos, Michel
    Bensman, Albert
    Fakhoury, May
    Jacqz-Aigrain, Evelyne
    THERAPEUTIC DRUG MONITORING, 2009, 31 (05) : 662 - 662
  • [16] Advagraf® with or without an induction therapy for de novo kidney-transplant recipients
    Noble, Johan
    Jouve, Thomas
    Rostaing, Lionel
    Malvezzi, Paolo
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (06) : 461 - 467
  • [17] Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients
    Zhao, W.
    Elie, V.
    Roussey, G.
    Brochard, K.
    Niaudet, P.
    Leroy, V.
    Loirat, C.
    Cochat, P.
    Cloarec, S.
    Andre, J. L.
    Garaix, F.
    Bensman, A.
    Fakhoury, M.
    Jacqz-Aigrain, E.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 86 (06) : 609 - 618
  • [18] Effect of denosumab on trabecular bone score in de novo kidney transplant recipients
    Bonani, Marco
    Frey, Diana
    Graf, Nicole
    Wuthrich, Rudolf P.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (10) : 1773 - 1780
  • [19] De Novo Anti-HLA Sensitization in Pediatric Kidney Transplant Recipients
    Vila-Santandreu, A.
    Camacho, J.
    Vila-Cots, J.
    Ramos, M.
    Gondra, L.
    Martorell, J.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 672 - 672
  • [20] Racial Differences in Tacrolimus Xr Dosing in De Novo Kidney Transplant Recipients
    Patel, N.
    Carcella, T.
    Bartlett, F.
    Rohan, V.
    Taber, D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 818 - 818
12345